Heart Failure Endpoint Evaluation with the Angiotensin II Antagonist Losartany课件.pptVIP

ARB VS ACEI ONTARGET ACE-inhibitors (e.g. ramipril in the HOPE trial) reduces CV death, MI, stroke and HF hosp in those with CVD or DM in the absence of ventricular dysfunction or heart failure ACE-inhibitors are not tolerated by 15% to 25% of patients Will an ARB (telmisartan) be as effective and better tolerated? * * * * * * * * Heart Failure Endpoint Evaluation with the Angiotensin II Antagonist Losartan (HEAAL)山东省立医院 商德亚 研 究 背 景 安慰剂对照组心衰治疗 VAL-HeFT VAL-HeFT VAL-HeFT VAL-HeFT VAL-HeFT VAL-HeFT CHARM Added: Candesartan in Heart failure: Assessment of Reduction in Mortal